Harrow Health, 11875 Stock Current Valuation
| HROWM Stock | 26.11 0.06 0.23% |
Valuation analysis of Harrow Health, 11875 helps investors to measure Harrow Health,'s intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 3rd of December 2024, Enterprise Value Over EBITDA is likely to grow to 103.45. Also, Enterprise Value Multiple is likely to grow to 103.45.
Fairly Valued
Today
Please note that Harrow Health,'s price fluctuation is very steady at this time. Calculation of the real value of Harrow Health, 11875 is based on 3 months time horizon. Increasing Harrow Health,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Harrow stock is determined by what a typical buyer is willing to pay for full or partial control of Harrow Health, 11875. Since Harrow Health, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Harrow Stock. However, Harrow Health,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 26.11 | Real 26.1 | Hype 26.17 | Naive 26.05 |
The intrinsic value of Harrow Health,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Harrow Health,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Harrow Health, 11875 helps investors to forecast how Harrow stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Harrow Health, more accurately as focusing exclusively on Harrow Health,'s fundamentals will not take into account other important factors: Harrow Health, 11875 Company Current Valuation Analysis
Harrow Health,'s Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Harrow Current Valuation Historical Pattern
Today, most investors in Harrow Health, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Harrow Health,'s growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Harrow Health, current valuation as a starting point in their analysis.
Harrow Health, Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Harrow Health, 11875 has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Drug Manufacturers - Specialty & Generic industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Harrow Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Harrow Health,'s direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Harrow Health, could also be used in its relative valuation, which is a method of valuing Harrow Health, by comparing valuation metrics of similar companies.Harrow Health, is currently under evaluation in current valuation category among its peers.
Harrow Health, Current Valuation Drivers
We derive many important indicators used in calculating different scores of Harrow Health, from analyzing Harrow Health,'s financial statements. These drivers represent accounts that assess Harrow Health,'s ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Harrow Health,'s important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 626.0M | 640.1M | 661.4M | 688.7M | 841.5M | 883.6M | |
| Enterprise Value | 642.0M | 659.4M | 697.2M | 704.7M | 957.9M | 1.0B |
About Harrow Health, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Harrow Health, 11875's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Harrow Health, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Harrow Health, 11875 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Harrow Health, Piotroski F Score and Harrow Health, Altman Z Score analysis. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health,. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Harrow Health, 11875 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health,'s value that differs from its market value or its book value, called intrinsic value, which is Harrow Health,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health,'s market value can be influenced by many factors that don't directly affect Harrow Health,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.